Amber Implants has advanced its pivotal EXPAND clinical study evaluating the VCFix Spinal System in defined patients with vertebral compression fractures.
EXPAND is a prospective, multicenter European clinical evaluation of VCFix to assess safety, performance, and clinical outcomes associated with vertebral reconstruction using VCFix in patients with vertebral compression fractures where anatomic restoration and structural support may be clinically meaningful, including use in a standalone configuration (with or without bone cement). Additional clinical participation is expected as enrollment continues across Europe.
Amber Implants continues to advance regulatory and commercialization activities in both Europe and the United States. The company expects ongoing clinical experience and evidence generation to support physician education, market development initiatives, and disciplined adoption in defined vertebral fracture populations.
Amber Implants has advanced its pivotal EXPAND clinical study evaluating the VCFix Spinal System in defined patients with vertebral compression fractures.
EXPAND is a prospective, multicenter European clinical evaluation of VCFix to assess safety, performance, and clinical outcomes associated with vertebral reconstruction using VCFix in...
Amber Implants has advanced its pivotal EXPAND clinical study evaluating the VCFix Spinal System in defined patients with vertebral compression fractures.
EXPAND is a prospective, multicenter European clinical evaluation of VCFix to assess safety, performance, and clinical outcomes associated with vertebral reconstruction using VCFix in patients with vertebral compression fractures where anatomic restoration and structural support may be clinically meaningful, including use in a standalone configuration (with or without bone cement). Additional clinical participation is expected as enrollment continues across Europe.
Amber Implants continues to advance regulatory and commercialization activities in both Europe and the United States. The company expects ongoing clinical experience and evidence generation to support physician education, market development initiatives, and disciplined adoption in defined vertebral fracture populations.
Copy to clipboard 
